The first and only FDA-cleared diagnostic tests to provide species identification of sepsis-causing bacterial and fungal pathogens, directly from a whole blood sample and independent of a positive blood culture.
T2Candida enabled the detection of candidemia 29 hours before a positive blood culture was returned. Early detection allowed for the rapid initiation of antifungal therapy in a critically ill COVID-19 patient.
Real stories about the positive impact of T2 Biosystems on clinical decisions and outcomes
Sepsis is a burden on healthcare and patients, contributing to: